Get the app!
Back to Trades
Sell4

LEMAITRE VASCULAR INC

LMAT

Total Value
$1.8M
Net $999.2K sold
Sales
$999.2K
3 transactions

Company Information

Ticker Symbol
LMAT
CIK
0001158895

Insider Information

Role
President and Director, Director
DirectorOfficer
Location
BURLINGTON, MA

Filing Details

Filing Date
Aug 13, 2025
Transaction Date
Aug 11, 2025
Accession Number
0001437749-25-026575
Form Type
4
Net Trading Amount
-$999.2K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Aug 11, 2025Common Stock3,979$37.29Exercise$148.4K
Aug 11, 2025Common Stock123$35.48Exercise$4.4K
Aug 11, 2025Common Stock3,718$92.53Sale$344.0K
Aug 11, 2025Common Stock384$91.55Sale$35.2K
Aug 11, 2025Common Stock6,713$37.29Exercise$250.3K
Aug 11, 2025Common Stock6,713$92.35Sale$620.0K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Aug 11, 2025Derivative123$35.48Exercise$4.4K
Aug 11, 2025Derivative3,979$37.29Exercise$148.4K
Aug 11, 2025Derivative6,713$37.29Exercise$250.3K

Footnotes

  1. (F1)Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
  2. (F2)The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.91 to $92.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  3. (F3)The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $91.89. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  4. (F4)The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.045 to $93.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  5. (F5)This option is fully vested and exercisable.
  6. (F6)This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.